Model
Edge
Lyell Immunopharma Inc.
0001907345
Filing Type
4
Filing Date
2/13/2022
Updated
2/14/22, 1:59 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership